A multi-centre, randomised study of Zoledronic Acid versus Observation in Patients with Asymptomatic Myeloma

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003854-33

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To define the time to the first skeletal event in patients with asymptomatic myeloma treated or not with Zoledronic Acid 4 mg administered as 15-minute infusion every 4 weeks for at maximum 24 months.


Critère d'inclusion

  • Newly diagnosed asymptomatic MM

Liens